These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 9334462)

  • 41. Atherosclerosis, oxidative stress and glutathione peroxidase-1: a new kid on the block.
    Lackner KJ; Blankenberg S
    Ital Heart J; 2004 Mar; 5(3):169-72. PubMed ID: 15119497
    [No Abstract]   [Full Text] [Related]  

  • 42. Oxidized low-density lipoprotein, a two-faced Janus in coronary artery disease?
    Parthasarathy S; Santanam N; Augé N
    Biochem Pharmacol; 1998 Aug; 56(3):279-84. PubMed ID: 9744562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [New pharmaceuticals for patients with atherosclerosis are under development. Antioxidants inhibit LDL modification].
    Björkhem I; Berglund L
    Lakartidningen; 1989 Sep; 86(39):3249-50, 3255. PubMed ID: 2796509
    [No Abstract]   [Full Text] [Related]  

  • 44. [Blood sugar concentration dynamics in experimental atherosclerosis and coronary insufficiency caused by limitation of movement in rabbits].
    Tiavokin VV
    Biull Eksp Biol Med; 1968 Dec; 66(12):27-8. PubMed ID: 5742303
    [No Abstract]   [Full Text] [Related]  

  • 45. Oxidative modification of lipoproteins--impact on atherosclerosis.
    Naruszewicz M
    Can J Cardiol; 1991; 7(6):VII-VIII. PubMed ID: 1893298
    [No Abstract]   [Full Text] [Related]  

  • 46. Atherosclerosis.
    Abuja PM
    Curr Opin Lipidol; 2003 Dec; 14(6):647-50. PubMed ID: 14624144
    [No Abstract]   [Full Text] [Related]  

  • 47. Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action.
    Keaney JF; Vita JA
    Prog Cardiovasc Dis; 1995; 38(2):129-54. PubMed ID: 7568903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The arterial wall and the process of atherosclerosis.
    Scott PJ
    N Z Med J; 1973 Jan; 77(488):1-6. PubMed ID: 4349813
    [No Abstract]   [Full Text] [Related]  

  • 49. Dietary and pharmacological antioxidants in atherosclerosis.
    Stocker R
    Curr Opin Lipidol; 1999 Dec; 10(6):589-97. PubMed ID: 10680053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sialic acid content of LDL in coronary artery disease: no evidence of desialylation in subjects with coronary stenosis and increased levels in subjects with extensive atherosclerosis and acute myocardial infarction: relation between desialylation and in vitro peroxidation.
    Chappey B; Beyssen B; Foos E; Ledru F; Guermonprez JL; Gaux JC; Myara I
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):876-83. PubMed ID: 9633926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipid peroxidation in mouse models of atherosclerosis.
    Praticò D
    Trends Cardiovasc Med; 2001; 11(3-4):112-6. PubMed ID: 11685999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antioxidants, cholesterol, and ischaemic heart disease: CHAOS or confusion?
    Winder AF
    J Clin Pathol; 1997 Apr; 50(4):269-70. PubMed ID: 9215138
    [No Abstract]   [Full Text] [Related]  

  • 53. Animal studies on antioxidants.
    Afridi N; Keaney JF
    J Cardiovasc Risk; 1996 Aug; 3(4):358-62. PubMed ID: 8946265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Modified lipoproteins and atherogenesis].
    Fruchart JC; Sauzières J; Plancke MO; Luc G; Clavey V
    Presse Med; 1989 Apr; 18(14):701-2. PubMed ID: 2524746
    [No Abstract]   [Full Text] [Related]  

  • 55. Coronary artery disease and antioxidants--is there a role for carvedilol?
    Landray MJ; Kendall MJ
    J Clin Pharm Ther; 1997 Feb; 22(1):3-5. PubMed ID: 9292396
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of antioxidants against atherosclerosis.
    Niki E; Noguchi N
    Mol Cell Biochem; 2002; 234-235(1-2):19-25. PubMed ID: 12162433
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antioxidants in peripheral arterial disease.
    Violi F; Loffredo L; Marcoccia A
    Curr Drug Targets Cardiovasc Haematol Disord; 2004 Sep; 4(3):289-94. PubMed ID: 15379622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Glycosaminoglycans-lipoproteins in coronary atherosclerosis].
    Neverov IV
    Sov Med; 1975 Apr; (4):16-9. PubMed ID: 127389
    [No Abstract]   [Full Text] [Related]  

  • 59. [Vitamin E, antioxidants and atherosclerosis].
    Lecerf JM; Luc G; Fruchart JC
    Rev Med Interne; 1994; 15(10):641-9. PubMed ID: 7800984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A critical look at the evidence for the oxidation of LDL in atherogenesis.
    Steinberg D
    Atherosclerosis; 1997 Jun; 131 Suppl():S5-7. PubMed ID: 9253467
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.